Secondary diffuse large B-cell lymphoma of the central nervous system: the need for better predictors

被引：1
|
作者：
Roschewski, Mark [1 ]
Dunleavy, Kieron [1 ]
机构：
[1] NCI, Lymphoid Malignancies Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
来源：
LEUKEMIA & LYMPHOMA | 2015年 / 56卷 / 06期
关键词：
OCCULT LEPTOMENINGEAL DISEASE; NON-HODGKINS-LYMPHOMA; DOUBLE-HIT LYMPHOMA; RISK-FACTORS; ELDERLY-PATIENTS; RITUXIMAB; RELAPSE; INVOLVEMENT; PROPHYLAXIS; RECURRENCE;
D O I：
10.3109/10428194.2015.1016936
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1583 / 1584
页数：2
相关论文
共 50 条
  • [21] Central nervous system relapse in patients with diffuse large B-cell lymphoma: analysis of incidence and prognostic factors
    Uni, Masahiro
    Kagoya, Yuki
    Nannya, Yasuhito
    Nakamura, Fumihiko
    Kurokawa, Mineo
    LEUKEMIA & LYMPHOMA, 2015, 56 (06) : 1869 - 1871
  • [22] Controversies in central nervous system prophylaxis of high-risk diffuse large B-cell lymphoma
    Bobillo, Sabela
    Wilson, Matthew R.
    Cwynarski, Kate
    CURRENT OPINION IN ONCOLOGY, 2023, 35 (05) : 382 - 388
  • [23] Intrathecal Central Nervous System Prophylaxis in Patients With Diffuse Large B-cell Lymphoma at an Academic Healthcare System
    Hall, Kevin H.
    Valla, Kelly
    Flowers, Christopher R.
    Cohen, Jonathon B.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (02) : 89 - 94
  • [24] Diffuse large B-cell lymphoma with involvement of the kidney: outcome and risk of central nervous system relapse
    Villa, Diego
    Connors, Joseph M.
    Sehn, Laurie H.
    Gascoyne, Randy D.
    Savage, Kerry J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (07): : 1002 - 1007
  • [25] Isolated central nervous system relapses in primary mediastinal large B-cell lymphoma after CHOP-like chemotherapy with or without Rituximab
    Papageorgiou, Sotirios G.
    Diamantopoulos, Panayiotis
    Levidou, Georgia
    Angelopoulou, Maria K.
    Economopoulou, Panagiota
    Efthimiou, Anna
    Constantinou, Nikos
    Katsigiannis, Andreas
    Korkolopoulou, Penelope
    Pappa, Vassiliki
    Economopoulou, Christina
    Georgiou, George
    Dimou, Maria
    Tsirigotis, Panagiotis
    Kyrtsonis, Marie-Christine
    Kotsianidis, Ioannis
    Kalpadakis, Christina
    Dimopoulos, Meletios-Athanassios
    Beris, Photis
    Meletis, John
    Pangalis, Gerassimos A.
    Dervenoulas, John
    Panayiotidis, Panayiotis
    Vassilakopoulos, Theodoros P.
    HEMATOLOGICAL ONCOLOGY, 2013, 31 (01) : 10 - 17
  • [26] The prevention of central nervous system relapse in diffuse large B-cell lymphoma: a British Society for Haematology good practice paper
    McKay, Pamela
    Wilson, Matthew R.
    Chaganti, Sridhar
    Smith, Jeffery
    Fox, Christopher P.
    Cwynarski, Kate
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (05) : 708 - 714
  • [27] Central nervous system relapse of diffuse large B-cell lymphoma in the rituximab era: results of the UK NCRI R-CHOP-14 versus 21 trial
    Gleeson, M.
    Counsell, N.
    Cunningham, D.
    Chadwick, N.
    Lawrie, A.
    Hawkes, E. A.
    McMillan, A.
    Ardeshna, K. M.
    Jack, A.
    Smith, P.
    Mouncey, P.
    Pocock, C.
    Radford, J. A.
    Davies, J.
    Turner, D.
    Kruger, A.
    Johnson, P.
    Gambell, J.
    Linch, D.
    ANNALS OF ONCOLOGY, 2017, 28 (10) : 2511 - 2516
  • [28] About time: why central nervous system prophylaxis timing in diffuse large B-cell lymphoma matters and does the protocol need updating?
    Lewis, Katharine Louise
    Cheah, Chan Yoon
    EXPERT REVIEW OF HEMATOLOGY, 2022, 15 (11) : 959 - 962
  • [29] Clinical Effect of CD25 on the Prognosis of Diffuse Large B Cell Lymphoma with Secondary Central Nervous System Relapse
    Oka, Satoko
    Ono, Kazuo
    Nohgawa, Masaharu
    PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (03) : 1843 - 1850
  • [30] Current strategies in the diagnosis of diffuse large B-cell lymphoma of the central nervous system
    Baraniskin, Alexander
    Deckert, Martina
    Schulte-Altedorneburg, Gernot
    Schlegel, Uwe
    Schroers, Roland
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 156 (04) : 421 - 432
12345